Skip to main content
. Author manuscript; available in PMC: 2010 Mar 12.
Published in final edited form as: J Med Chem. 2009 Mar 12;52(5):1471–1476. doi: 10.1021/jm801549b

Figure 1.

Figure 1

Schematic representation of the interactions between vancomycin (1), vancomycin aglycon (5), and model ligands N,N′-Ac2-l-Lys-d-Ala-d-Ala (2) and N,N′-Ac2-l-Lys-d-Ala-d-Lac (3).